Cargando…
Arsenic speciation in saliva of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment
Arsenic trioxide has been successfully used as a therapeutic in the treatment of acute promyelocytic leukemia (APL). Detailed monitoring of the therapeutic arsenic and its metabolites in various accessible specimens of APL patients can contribute to improving treatment efficacy and minimizing arseni...
Autores principales: | Chen, Baowei, Cao, Fenglin, Yuan, Chungang, Lu, Xiufen, Shen, Shengwen, Zhou, Jin, Le, X. Chris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565090/ https://www.ncbi.nlm.nih.gov/pubmed/23318765 http://dx.doi.org/10.1007/s00216-012-6700-5 |
Ejemplares similares
-
Speciation of arsenic trioxide metabolites in peripheral blood and bone marrow from an acute promyelocytic leukemia patient
por: Iriyama, Noriyoshi, et al.
Publicado: (2012) -
A Review of Arsenic Trioxide and Acute Promyelocytic Leukemia
por: Alimoghaddam, Kamran
Publicado: (2014) -
On arsenic trioxide in the clinical treatment of acute promyelocytic leukemia
por: Zhang, Peng
Publicado: (2017) -
Treatment of Acute Promyelocytic Leukemia with Single-Agent Arsenic Trioxide
por: Mathews, Vikram, et al.
Publicado: (2011) -
Successful treatment of acute promyelocytic leukemia in a patient undergoing hemodialysis with arsenic trioxide
por: Hashimoto, Akiko, et al.
Publicado: (2021)